Novo Nordisk says to market improved insulin in 2013

Dec 23, 2010

Danish pharmaceutical company Novo Nordisk said Thursday it planned to put a new insulin product on the market by 2013 after tests showed advantages to the widely sold diabetes drug Lantus.

"We believe that this ultra long-acting fourth-generation will be a serious competitor to Lantus when it reaches the market in 2013," said Mike Rulis, a spokesman for the company which is a leader in treatments for .

Novo Nordisk on Thursday released results of studies it said showed that its product, Degludec, reduced the risk of dangerous drops in blood sugar levels during the night by 25 percent compared to Lantus, which is manufactured by the French company Sanofi-Aventis.

"Nocturnal hypoglycaemia -- episodes of too low blood sugar during the night -- is a major worry for many people with diabetes," Mads Krogsgaard Thomsen, Novo Nordisk's executive vice president and chief science officer, was quoted as saying in a statement.

According to the World Health Organisation, more than 220 million people worldwide have diabetes, which occurs when the body cannot produce insulin to regulate levels or cannot use natural insulin effectively due to overweight and absence of sufficient exercise.

Explore further: National Cancer Institute supports next-generation Austrian HPV vaccine

add to favorites email to friend print save as pdf

Related Stories

Impaired fat-burning gene worsens diabetes

Feb 07, 2008

Researchers at the Swedish medical university Karolinska Institutet have in collaboration with researchers from Finland, China, Japan and the US discovered new cellular mechanisms that lead to in insulin resistance in people ...

FDA notes heart events, tumors with Novo drug

Mar 31, 2009

(AP) -- Federal health officials say a potential blockbuster diabetes drug from Novo Nordisk appears to work. But they say questions remain about its effect on the heart and other organs.

Recommended for you

A new tool in drug overdose prevention

Oct 30, 2014

The Center for Disease Control reported earlier this month that the heroin overdose death rate across 28 states it surveyed doubled between 2010 and 2012. This sharp increase and the chilling statistics that say more than 11 ...

Nasal spray treats heroin overdose

Oct 28, 2014

"Every year, drug overdoses are responsible for roughly 1000 ambulance calls in Oslo," says Arne Skulberg, an anaesthesiologist, a PhD candidate at NTNU and the 2014 winner of Norway's Researcher Grand Prix ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.